Citibank’s Carl McDonald, one of Wall Street’s top sell-side analysts covering health insurers, suspects that the firms which he covers are being too optimistic about the money they’ll receive from Obamacare’s risk corridors.
Read the entire column at NCPA's Health Policy Blog.
Research and commentary from a former senior executive in the U.S. Department of Health & Human Services
No comments:
Post a Comment